Differences between subjects with incident cases and control subjects without onset of neuropathy were observed for the baseline monofilament score and the VPT values.
We conducted population-based studies of Hodgkin lymphoma (HL), Multiple Myeloma (MM), non-Hodgkin's Lymphoma (NHL), and Soft Tissue Sarcoma (STS) among male incident case and control subjects in six Canadian provinces.
Simultaneously, in order to compare the family history of cancer, we conducted population-based case-control studies of Hodgkin Lymphoma, Multiple Myeloma, Non-Hodgkin's Lymphoma and Soft Tissue Sarcoma among male incident case and control subjects in six Canadian provinces using postal questionnaires in order to compare details of family history of cancer among them.
Involvement of clinical chemistry: Table 2 shows that the patterns of utilizing laboratory medicine over the two years of observation do not differ between the incident and the control group.
ORs were interpreted as incidence rate ratios, as this case control study was based on incident cases and controls were sampled by incidence density sampling (14, 22, 23).
Since this effect was largely caused by one sub-population only (incident cases and controls from the Rotterdam study), we chose to include two additional study populations.
PCPs themselves are visited by nearly all (95%) incident cases and controls without a referral.
The physical comorbidities included in this analysis were quite rare, with most of them present in less than 1% in both, incident users and controls.
Our study has the advantages of recruiting incident cases and controls from population-based sources covering a large geographical area of Canada.
When we stratified the cases and matched controls by prevalent user status, the results were still consistent with those of the primary analysis; the triple therapy combination was associated with an increased risk of acute kidney injury in both prevalent and incident cases and controls.
